Diuretic therapy in congestive heart failure

Abstract In heart failure, fluid overload is a major pathological mechanism leading to vascular congestion, pulmonary congestion and elevated jugular venous pressures. Diuretics play a significant role in the management of patients with congestive heart failure. It is used to relieve the congestive symptoms of heart failure. However, the appropriate use of diuretics remains challenging due to various complications like electrolyte abnormalities, worsening renal function and diuretic resistance. This has prompted towards the search of safer and effective alternatives. This review evaluates the use of diuretics in congestive heart failure and discusses the complications of different types of diuretics, which is essential for successful management of congestion in patients with heart failure and hence to optimise the outcome for the patients.

• Publication year

  2021

• Venue

  Acta Cardiologica

• Publication date

  2021-03-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/00015385.2021.1878423PMID 33653227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.

  2019cited by this paper
• Hyperkalemia in heart failure

  2019cited by this paper
• Prevalence and outcome of diuretic resistance in heart failure

  2019cited by this paper
• Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis

  2019cited by this paper
• The Role of the Clinical Examination in Patients With Heart Failure.

  2018cited by this paper
• A 2018 overview of diuretic resistance in heart failure.

  2018cited by this paper
• Hypokalemia: a clinical update

  2018cited by this paper
• Diagnosis and management of adults with chronic heart failure: summary of updated NICE guidance

  2018cited by this paper
• Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system.

  2017cited by this paper
• A perspective on diuretic resistance in chronic congestive heart failure

  2017cited by this paper
• 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

  2017cited by this paper
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2016cited by this paper
• Hyperkalemia in Heart Failure.

  2016cited by this paper
• Management of Cardio-Renal Syndrome and Diuretic Resistance

  2016cited by this paper
• Diuretic response and renal function in heart failure

  2016cited by this paper
• Diuretic Therapy in Heart Failure - Current Approaches.

  2015cited by this paper
• Fluid Management in Patients with Chronic Heart Failure

  2015cited by this paper
• Fluid Management in Patients with Chronic Heart Failure.

  2015cited by this paper
• Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation.

  2014cited by this paper
• Use of Diuretics and Risk of Incident Gout: A Population‐Based Case–Control Study

  2014cited by this paper
• Diuretic resistance and its management.

  2014cited by this paper
• Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

  2013cited by this paper
• Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association

  2013cited by this paper
• Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study.

  2012cited by this paper
• Should torsemide be the loop diuretic of choice in systolic heart failure?

  2012cited by this paper
• Comparative Efficacy and tolerability of Lasoride and Spiromide in congestive Cardiac Failure

  2011cited by this paper
• Update in diuretic therapy: clinical pharmacology.

  2011cited by this paper
• Thiazide and Loop Diuretics

  2011cited by this paper
• Metabolic complications associated with use of diuretics.

  2011cited by this paper
• A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction.

  2011cited by this paper
• Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy

  2010cited by this paper
• Loop diuretics for heart failure-associated hyponatremia.

  2010cited by this paper
• HFSA 2010 Comprehensive Heart Failure Practice Guideline.

  2010cited by this paper
• Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.

  2009cited by this paper
• A Comprehensive Review of the Loop Diuretics: Should Furosemide Be First Line?

  2009cited by this paper
• Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.

  2008cited by this paper
• Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE Trial

  2007cited by this paper
• Anemia, renal dysfunction, and their interaction in patients with chronic heart failure.

  2006cited by this paper
• The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005).

  2005cited by this paper
• Thiazide diuretics and the risk of gallbladder disease requiring surgery in women.

  2005cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

  2005cited by this paper
• Continuous infusion versus bolus injection of loop diuretics in congestive heart failure.

  2005cited by this paper
• Reassessing treatment of acute heart failure syndromes: the ADHERE Registry

  2005cited by this paper
• Continuous infusion versus bolus injection of loop diuretics in congestive heart failure.

  2004cited by this paper
• Mechanisms and management of diuretic resistance in congestive heart failure

  2003cited by this paper
• Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases

  2003cited by this paper
• Torasemide in chronic heart failure: results of the TORIC study

  2002cited by this paper
• Extracorporeal Ultrafiltration for the Treatment of Overhydration and Congestive Heart Failure

  2002cited by this paper
• Potentiators and bolus intravenous furosemide.

  2001cited by this paper
• Clinical inquiries. How soon should serum potassium levels be monitored for patients started on diuretics?

  2001cited by this paper
• Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.

  2001cited by this paper
• New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice.

  2000cited by this paper
• Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.

  1999cited by this paper
• Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction.

  1999cited by this paper
• Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter

  1999cited by this paper
• The health care costs of heart failure in Sweden

  1999cited by this paper
• Diuretic therapy.

  1998cited by this paper
• Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

  1997cited by this paper
• Increased toxicity of high‐dose furosemide versus low‐dose dopamine in the treatment of refractory congestive heart failure

  1997cited by this paper
• Haemodynamic effects of diuretics in heart failure.

  1994cited by this paper
• Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients.

  1993cited by this paper
• Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men.

  1992cited by this paper
• The physiologic basis of diuretic synergism: its role in treating diuretic resistance.

  1991cited by this paper
• Development of Acute Tolerance to Bumetanide: Constant-Rate Infusion Studies

  1988cited by this paper
• Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913.

  1987cited by this paper
• Development of Acute Tolerance to Bumetanide: Bolus Injection Studies

  1987cited by this paper
• Diuretics in heart failure.

  1986cited by this paper
• Control by drugs of renal potassium handling.

  1986cited by this paper
• The metabolic effects of thiazide therapy in the elderly: a population study.

  1986cited by this paper
• An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients.

  1985cited by this paper
• Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.

  1985cited by this paper
• Response of the kidney to furosemide. I. Effects of salt intake and renal compensation.

  1983cited by this paper
• Comparative effect of diuretics on renal water excretion in hyponatraemic oedematous disorders.

  1982cited by this paper
• Effects of magnesium infusions in diuretic induced hyponatraemia.

  1981cited by this paper
• Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients.

  1981cited by this paper
• Furosemide-induced ototoxicity.

  1979cited by this paper
• The natural history of congestive heart failure: the Framingham study.

  1971cited by this paper
• Diuretic-induced hyponatremia.

  1971cited by this paper
• [The mechanism of action of diuretics].

  1966cited by this paper
• Diuretic therapy.

  1961cited by this paper

• Relationship between chronic heart and venous insufficiency: possible mechanisms and clinical research findings

  2026cites this paper
• Enhancing the evidence base: constructive feedback on the comparative effectiveness of torsemide and furosemide in heart failure

  2025cites this paper
• Chronic venous insufficiency in heart failure: exploring a reciprocal influence on cardiovascular health

  2025cites this paper
• Diagnostic Methods for Pulmonary Congestion and Pleural Effusion: A Protocol for a Systematic Review and Meta‐Analysis

  2025cites this paper
• Advancing risk stratification in heart failure: integrating hemodynamic, biochemical, and computational markers

  2025cites this paper
• Bifunctional competitive antigen enhanced DLS Immunosensor for the ultrasensitive detection of furosemide in slimming products.

  2025cites this paper
• Potential drug–drug interactions among hospitalised cardiac patients in Nepal: a prospective observational study

  2025cites this paper
• Breaking new ground in heart failure management: novel therapies and future frontiers

  2025cites this paper
• Efficacy and safety of recombinant human brain natriuretic peptide combined with sacubitril/valsartan in patients with congestive heart failure and rapid atrial fibrillation based on echocardiographic assessment

  2025cites this paper
• Influencing factors analysis of clinical effect of heart failure patients treated with ivabradine and metoprolol succinate and construction and validation of nomogram prediction model

  2025cites this paper
• Hubungan Kerasionalan Obat Antihipertensi Dengan Kontrol Tekanan Darah Pada Pasien Stroke Non-Hemoragik di Instalasi Rawat Inap RS X Surakarta Tahun 2024

  2025cites this paper
• Relationship Between Congestive Heart Failure and the Dietary Index of Gut Microbiota: Information From the National Health and Nutrition Examination Survey 2007–2018

  2025cites this paper
• Torsemide vs. furosemide in congestive heart failure: a systematic-review and meta-analysis on mortality and rehospitalization

  2025cites this paper
• Biosensors with left ventricular assist devices

  2024cites this paper
• Trastornos electrolíticos inducidos por diuréticos de asa en los adultos mayores. Revisión sistemática

  2024cites this paper
• Challenging and target-based shifting strategies for heart failure treatment: An update from the last decades.

  2024cites this paper
• Role of Lymphatics in Heart Failure

  2023cites this paper
• Salsolinol improves angiotensin II‑induced myocardial fibrosis in vitro via inhibition of LSD1 through regulation of the STAT3/Notch‑1 signaling pathway

  2023cites this paper
• Management of Hyponatremia in Heart Failure: Practical Considerations

  2023cites this paper
• Poly(3,4-ethylenedioxythiophene):Polystyrene Sulfonate-Modified Electrode for the Detection of Furosemide in Pharmaceutical Products

  2023cites this paper
• Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy

  2022cites this paper
• Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin

  2022cites this paper
• Recent advances in implantable hydrogels for treating heart failure

  2022cites this paper